New Berlin, WI, United States of America

Matthew Grieshop

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Matthew Grieshop

Introduction

Matthew Grieshop is an accomplished inventor based in New Berlin, Wisconsin. He has made significant contributions to the field of gene expression modulation, holding a total of 2 patents. His work focuses on developing methods and compositions that enhance the understanding and manipulation of genetic material.

Latest Patents

Grieshop's latest patents include "Methods and compositions for modulating gene expression" and "Compounds and methods for modulating frataxin expression." Both patents relate to compositions and methods for modulating the expression of genes, utilizing target oligonucleotide sequences that contain repeats of specific nucleotide sequences. The technology involves agents characterized by a formula A-L-B, where -L- is a linker, A- is a Brd4 binding moiety, and -B is a nucleic acid binding moiety, such as a polyamide or complementary oligonucleotide, that specifically binds to the target oligonucleotide sequence.

Career Highlights

Grieshop is affiliated with the Wisconsin Alumni Research Foundation, where he continues to innovate and contribute to advancements in genetic research. His work has the potential to impact various fields, including medicine and biotechnology.

Collaborations

Some of his notable coworkers include Aseem Zoe Ansari and Graham Erwin, who collaborate with him on various research projects.

Conclusion

Matthew Grieshop's contributions to gene expression modulation through his patents and work at the Wisconsin Alumni Research Foundation highlight his role as a significant innovator in the field. His research continues to pave the way for advancements in genetic technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…